TriangleNCT00567567 · OUTCOME
Proportion of Patients With Neuroblastoma Detected in Bone Marrow and Peripheral Blood Using RT-PCR Technique
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- Not reported
- Unit
- Not reported
- Interval / dispersion
- Not reported
- Time frame
- Baseline
What was measured
Will be calculated overall and by treatment arm.
Analysis population: Data were not collected to assess this study aim.
Groups in this outcome
Single HST (CEM)
Induction therapy + single myeloablative consolidation
Tandem HST (CEM), Randomly Assigned
Induction therapy + tandem myeloablative consolidation
All Eligible Patients
All Eligible Patients
| Group | Source count |
|---|---|
| Single HST (CEM) | 0 |
| Tandem HST (CEM), Randomly Assigned | 0 |
| All Eligible Patients | 0 |
Reported measurements
No numerical measurement classes were posted for this outcome. Missing is not zero.
Complete source fields
- denoms
- counts
- group Id
- OG000
- value
- 0
- group Id
- OG001
- value
- 0
- group Id
- OG002
- value
- 0
- units
- Participants
- description
- Will be calculated overall and by treatment arm.
- groups
- description
- Induction therapy + single myeloablative consolidation
- id
- OG000
- title
- Single HST (CEM)
- description
- Induction therapy + tandem myeloablative consolidation
- id
- OG001
- title
- Tandem HST (CEM), Randomly Assigned
- description
- All Eligible Patients
- id
- OG002
- title
- All Eligible Patients
- population Description
- Data were not collected to assess this study aim.
- reporting Status
- POSTED
- time Frame
- Baseline
- title
- Proportion of Patients With Neuroblastoma Detected in Bone Marrow and Peripheral Blood Using RT-PCR Technique
- type
- SECONDARY
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice